跳至主要内容
临床试验/NCT06166420
NCT06166420已完成不适用

Offering Home-based Versus Hospital-based HPV Counseling and Testing for Cervical Cancer Screening in Rural West Region of Cameroon: a Randomised Cluster Trial

Prof. Patrick Petignat1 个研究点 分布在 1 个国家目标入组 2,079 人开始时间: 2023年3月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,079
试验地点
1
主要终点
Number and percentage of participants who will complete full screening (HPV test +/- VIA/VILI +/- treatment when necessary) in both arms within 3 months of sensitization

研究概览

简要总结

Cervical cancer is a public health problem in Cameroon.In 2020, the country had a crude incidence of 20.2 per 100 000 women for an incidence to mortality ratio of 0.65. As for now, the country does not have a national screening program to combat the disease. Only 6% of cameroonian women have once been screened for cervical cancer. In order to increase screening uptake so as to reach 70% recommended by the World Health Organization (WHO), a home-based cervical cancer screening approach is proposed. The objective of our study is to compare two recruitment strategies for cervical cancer screening in rural Cameroon.

详细描述

In 2018, a 5 years cervical cancer screening project called: "Promoting Comprehensive Cervical Cancer Prevention and Better Women's Health in Low- and Medium Resource Settings in the Health District of Dschang" was launched in the West Region of Cameroon. The study aimed at screening 2000 women per year following screen-triage-treatment as recommended by WHO in a 3T approach: Test with HPV self-sampling test, Triage by visual assessement of the cervix with acetic acid and lugol (VIA/VILI), Treatment with thermal ablation. Despite sensitization using communication information channels, uptake of the screening was below the target. In order to increase uptake of the screening, this study proposes a home-based strategy using Community Health Workers (CHW). Community Health Workers (CHW) are lay members of the community who carry out health promotion activities after training. In a randomised controlled cluster trial, two recruitment strategies for cervical cancer screening will be compared: in one arm a team made up of a CHW and a nurse will do door-to-door sensitization and propose home-based HPV self-sampling test to eligible women and in the other arm CHW will do door-to-door sensitization and issue invitation cards to eligible women for hospital-based HPV self-sampling test. This study is nested in ongoing cervical cancer screening project.

Primary objective: To compare completeness of full screening between two different recruitment strategies in rural area: counselling and home-based HPV self-sampling test versus counselling and hospital-based HPV self-sampling test.

Secondary objectives:

  • To determine the proportion of women who will carry out an HPV self-sampling test in both strategies within 3 months of sensitization.
  • To determine the proportion of HPV positive women who will undergo VIA/VILI in both arms within 3 months.
  • To assess the acceptability of home self-sampling HPV test and perception of single versus 2 visits approaches.
  • To determine predictors of non-adherence to care-seeking for HPV positive women.
  • To determine the number of pre-cancers and/or cancers diagnosed in both arms and their treatment.
  • To calculate the economic cost of both strategies.

Mixed method design, quantitative and qualitative informations will be collected.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
30 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 30-49 years
  • Ability to understand study procedures and accepting voluntarily to participate by signing an informed consent form (ICF).
  • Non-inclusion criteria:
  • Pregnancy at the time of screening
  • History of cervical cancer screening by HPV test of less than 5 years (for HIV-negative women) or less than 3 years (for HIV positive women).
  • Intra-vaginal treatment

排除标准

  • Symptoms of cervical cancer (e.g. metrorrhagia, known pelvic mass)
  • Severe pre-existing medical conditions (e.g. advanced cancer, terminal renal failure)
  • Women who are not able to comply with the study protocol.
  • Previous hysterectomy
  • Known cervical cancer

结局指标

主要结局

Number and percentage of participants who will complete full screening (HPV test +/- VIA/VILI +/- treatment when necessary) in both arms within 3 months of sensitization

时间窗: 3 months

The number and percentage of participants who will do an HPV self test+/- VIA/VILI+/- treatment par study arm

次要结局

  • Number and percentage of women who will do an HPV test within 3 months of sensitization per study arm(3 months from sensitization)
  • Number and percentage of participants once tested HPVpositive who will link to the pelvic exam for visual assessment and treatment (if needed) within 3 months.(3 months from HPV self sample collection)
  • Identify barriers and enablers to the home-HPV self-sampling test.(4 months)
  • Identify barriers and enablers of linkage to VIA for HPV positive women(4 months)
  • Number of pre-cancers and/or cancers diagnosed in each study arm.(2 years)
  • Cost of each screening strategy.(2 years)

研究者

发起方
Prof. Patrick Petignat
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Prof. Patrick Petignat

Professor

University Hospital, Geneva

研究点 (1)

Loading locations...

相似试验